Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001258693-26-000013

CHIEF EXECUTIVE OFFICER sold 24,237 shares at an average $55.22 ($1,338,270)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −6,683 $54.28 $362,720 468,020 D: show line 1 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −9,137 $55.27 $504,956 458,883 D: show line 2 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −6,417 $56.12 $360,128 452,466 D: show line 3 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −312 $54.35 $16,956 134,903 I: show line 4 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −356 $55.23 $19,660 134,547 I: show line 5 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −332 $55.99 $18,590 134,215 I: show line 6 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −207 $54.22 $11,224 135,008 I: show line 7 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −602 $55.30 $33,289 134,406 I: show line 8 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-26 Sale 10b5-1 −191 $56.27 $10,747 134,215 I: show line 9 in the form
Open-market sales · 24,237 sh · avg $55.22 · $1,338,270
Loading xslF345X06/wk-form4_1782514151.xml…